Literature DB >> 27387321

Target identification for biologically active small molecules using chemical biology approaches.

Heesu Lee1,2, Jae Wook Lee3,4,5.   

Abstract

The identification and validation of the targets of biologically active molecules is an important step in the field of chemical biology. While recent advances in proteomic and genomic technology have accelerated this identification process, the discovery of small molecule targets remains the most challenging step. A general method for the identification of these small molecule targets has not yet been established. To overcome the difficulty in target identification, new technology derived from the fields of genomics, proteomics, and bioinformatics has been developed. To date, pull-down methods using small molecules immobilized on a solid support followed by mass spectrometry have been the most successful approach. Here, we discuss current procedures for target identification. We also review the most recent target identification approaches and present several examples that illustrate advanced target identification technology.

Keywords:  Affinity based approach; Chemical biology; Drug discovery; High throughput screen; Small molecule; Target identification

Mesh:

Substances:

Year:  2016        PMID: 27387321     DOI: 10.1007/s12272-016-0791-z

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  8 in total

Review 1.  Opportunities and challenges in phenotypic drug discovery: an industry perspective.

Authors:  John G Moffat; Fabien Vincent; Jonathan A Lee; Jörg Eder; Marco Prunotto
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

Review 2.  Unbiased Screens for Modifiers of Alpha-Synuclein Toxicity.

Authors:  Matthias Höllerhage; Marc Bickle; Günter U Höglinger
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

Review 3.  Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery.

Authors:  Masaki Hosoya; Katherine Czysz
Journal:  Cells       Date:  2016-12-21       Impact factor: 6.600

Review 4.  Experimental Strategies to Explore Drug Action and Resistance in Kinetoplastid Parasites.

Authors:  Magali Van den Kerkhof; Yann G-J Sterckx; Philippe Leprohon; Louis Maes; Guy Caljon
Journal:  Microorganisms       Date:  2020-06-24

Review 5.  Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery.

Authors:  Nicholas Ekow Thomford; Dimakatso Alice Senthebane; Arielle Rowe; Daniella Munro; Palesa Seele; Alfred Maroyi; Kevin Dzobo
Journal:  Int J Mol Sci       Date:  2018-05-25       Impact factor: 5.923

6.  An in silico Approach for Integrating Phenotypic and Target-based Approaches in Drug Discovery.

Authors:  Hiroaki Iwata; Ryosuke Kojima; Yasushi Okuno
Journal:  Mol Inform       Date:  2019-10-22       Impact factor: 3.353

7.  MGraphDTA: deep multiscale graph neural network for explainable drug-target binding affinity prediction.

Authors:  Ziduo Yang; Weihe Zhong; Lu Zhao; Calvin Yu-Chian Chen
Journal:  Chem Sci       Date:  2022-01-05       Impact factor: 9.825

8.  Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.

Authors:  Susan Wyllie; Michael Thomas; Stephen Patterson; Sabrinia Crouch; Manu De Rycker; Rhiannon Lowe; Stephanie Gresham; Michael D Urbaniak; Thomas D Otto; Laste Stojanovski; Frederick R C Simeons; Sujatha Manthri; Lorna M MacLean; Fabio Zuccotto; Nadine Homeyer; Hannah Pflaumer; Markus Boesche; Lalitha Sastry; Paul Connolly; Sebastian Albrecht; Matt Berriman; Gerard Drewes; David W Gray; Sonja Ghidelli-Disse; Susan Dixon; Jose M Fiandor; Paul G Wyatt; Michael A J Ferguson; Alan H Fairlamb; Timothy J Miles; Kevin D Read; Ian H Gilbert
Journal:  Nature       Date:  2018-07-25       Impact factor: 49.962

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.